Patents for A61P 23 - Anaesthetics (4,141)
06/2001
06/07/2001WO2001013780A3 Apparatus and method for anesthetizing the cervical region of a female
06/07/2001US20010002999 For oral administration comprising an analgesic with rapid onset of action and at least one systemically acting analgesic with sustained action, such as a combination of benzocaine and acetylsalicylic acid (ASA)
05/2001
05/31/2001WO2001038326A2 Imidazo-pyridine derivatives as ligands for gaba receptors
05/31/2001CA2392327A1 Imidazo-pyridine derivatives as ligands for gaba receptors
05/30/2001EP1102589A1 Topical compositions comprising an opioid analgesic and an nmda antagonist
05/23/2001EP1100780A1 Novel 2,3,3a,4,9,9a hexahydro-8-hydroxy-1h-benz f]indoles, a method for the production thereof, and their use as medicaments
05/22/2001US6235792 Phosphate salt of isopropyl-methyl- [2-(3-n-propoxyphenoxy)ethyl]amine
05/17/2001WO2001033942A1 Method for producing metabolites from plants cultivated in soil-less medium
05/16/2001EP1098871A1 $g(a)-AMINO ACID PHENYL ESTER DERIVATIVES
05/16/2001CN1295558A Novel local anesthetic compounds and uses
05/09/2001EP1096919A1 Systems and methods for local delivery of an agent
05/03/2001WO2001030844A1 Dna encoding human alpha1g-c t-type calcium channel
05/03/2001CA2389031A1 Dna encoding human alpha1g-c t-type calcium channel
05/02/2001EP1094818A1 Use of tricyclic antidepressants for local analgesia
05/01/2001US6225343 Compositions and methods comprising morphine gluconate
05/01/2001US6224857 Pharmaceutical preparations comprised of salts of hyaluronic acid with local anaesthetics
04/2001
04/26/2001WO2001028591A2 Injection vehicle for polymer-based formulations
04/19/2001WO2001026627A1 Liposome encapsulated silver salt compositions
04/19/2001DE19947453A1 Gas collection equipment used for e.g. moist gases containing xenon from anesthesia comprises pump and storage unit for gas
04/19/2001CA2387145A1 Liposome encapsulated silver salt compositions
04/18/2001EP0546160B1 Method of reversing local anesthesia and reagent system therefor
04/17/2001US6217889 Personal care articles
04/12/2001WO2001025235A1 Macrocyclic quinazolinones and their use as local anesthetics
04/12/2001WO2001025234A1 Quinazolinones and analogues and their use as local anesthetics
04/12/2001WO2001024774A1 Ortho ester lipids
04/12/2001CA2388864A1 Ortho ester lipids
04/05/2001WO2001022967A1 Compositions having improved stability
04/05/2001WO2001022907A1 Drug delivery of phase changing formulation
04/05/2001WO2001008657A3 Personal care articles
04/05/2001WO2000072820A3 Injectable anesthetic formulation
04/05/2001WO2000057877A8 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof
04/05/2001CA2385990A1 Compositions having improved stability
04/04/2001EP1087934A1 Aminocyclohexyl ether compounds and uses thereof
03/2001
03/27/2001US6207680 Heteroarylpiperidines and their use as antipsychotics and analgesics
03/22/2001WO2001019403A1 Liposomal mixture of local anesthetics and manufacturing method thereof
03/22/2001WO2001019366A1 Topical treatment for prevention of ocular infections
03/22/2001WO2001019361A2 Therapeutic uses of polymers and oligomers comprising gamma-hydroxybutyrate
03/21/2001CN1288464A 4-(2-keto-1-benzimidazolynyl) pipeidine compounds as ORL-1 receptor
03/20/2001CA2132841C Aminocyclohexylamides for antiarrhythmic and anaesthetic uses
03/15/2001WO2001017472A1 Using quaternary ammonium salts for transdermal drug delivery
03/15/2001WO2000077198A3 Identification and molecular characterisation of proteins, expressed in the tick salivary glands
03/15/2001WO2000066614A8 3α-HYDROXY-3β METHOXYMETHYL-21-HETEROCYCLE SUBSTITUTED STEROIDS WITH ANESTHETIC ACTIVITY
03/15/2001CA2384679A1 Using quaternary ammonium salts for transdermal drug delivery
03/13/2001US6201007 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
03/13/2001US6200599 Ortho ester lipids
03/07/2001EP1079833A1 Cocaine receptor binding ligands
03/07/2001EP1079813A2 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
03/07/2001CN1286264A Action of proinsulin associated peptide on dopamine transporter and its application in treating correlative diseases
03/06/2001US6197772 1- (1,2-disubstituted piperidinyl) -4-substituted piperazine derivatives
03/06/2001US6197324 Implanting local anesthetic into myocardial tissue
03/06/2001US6197323 Medicinal preparation containing a lipophilic inert gas
03/01/2001WO2001013780A2 Apparatus and method for anesthetizing the cervical region of a female
02/2001
02/28/2001EP1077684A1 Effervescent preparations
02/21/2001CN1284864A Novel formulation for use in pain management
02/15/2001WO2000062740A3 Skin care compositions containing combination of skin care actives
02/15/2001WO2000059483A3 Transdermal drug delivery devices comprising a polyurethane drug reservoir
02/13/2001US6187789 Muscle relaxants for emergency intubation and surgery
02/08/2001WO2001008657A2 Personal care articles
02/08/2001WO2001008632A2 Colloidal composition for esthetic correction
02/08/2001WO2000059851A8 Derivatives of venlafaxine and methods of preparing and using the same
02/08/2001CA2379538A1 Personal care articles
02/08/2001CA2378155A1 Colloidal composition for esthetic correction
02/07/2001EP1073415A1 Pharmaceutical compositions capable of being gelled
02/07/2001EP1073414A1 Use of pharmaceutical compositions capable of being gelled in periodontology
02/07/2001CN1283177A Process for the preparation of isopropyl-methyl-[2-(3-N-Propoxyphenoxy) ethyl] amine
01/2001
01/30/2001US6180136 Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use
01/25/2001WO2001005409A1 Novel spinal and epidural anaesthetic
01/23/2001USRE37029 Antipsychotic and analgesic agents
01/23/2001US6177445 Substituted isoquinolines as ultra short acting neuromuscular blockers
01/17/2001EP0808325B1 Androstane and pregnane series for allosteric modulation of gaba receptor
01/17/2001CN1280559A A noval phosphate salt of isopropyl-methyl-[-2-(3-n-propoxyphenoxy)ethyl] amine
01/10/2001EP1066245A1 Novel local anesthetic compounds and uses
01/10/2001CN1279607A Anaesthetic formulation
01/04/2001WO2001000247A1 Peptide-lipid conjugates, liposomes and liposomal drug delivery
01/04/2001CA2376859A1 Peptide-lipid conjugates, liposomes and liposomal drug delivery
12/2000
12/28/2000WO2000078728A1 Novel benzimidazole derivatives and pharmaceutical compositions comprising these compounds
12/28/2000WO2000078301A1 Anesthetic composition for intravenous injection comprising propofol
12/28/2000CA2373921A1 Novel benzimidazole derivatives and pharmaceutical compositions comprising these compounds
12/26/2000US6165503 Preparing gelled beads of a polyanionic polysaccharide which are cross-linked with a polyvalent cation, forming capsules having polycationic-polyanion membrane of polycationic polysaccharide on gelled beads, culturing the product capsule
12/21/2000WO2000077198A2 Identification and molecular characterisation of proteins, expressed in the tick salivary glands
12/21/2000WO2000076545A1 Anaesthetic formulation comprising an nmda-antagonist and an alpha-2 adrenergic agonist
12/21/2000WO2000076532A1 νO-CONOPEPTIDES AND THEIR USE AS LOCAL ANESTHETICS
12/21/2000WO2000076510A1 Dermal anesthetic agents
12/21/2000WO2000076314A1 Compositions and methods comprising morphine gluconate
12/21/2000WO2000045791A3 Method for controlling liposome size
12/21/2000CA2376865A1 Compositions and methods comprising morphine gluconate
12/21/2000CA2376421A1 Identification and molecular characterisation of proteins, expressed in the tick salivary glands
12/21/2000CA2376357A1 .mu.o-conopeptides and their use as local anesthetics
12/19/2000US6162462 Incubating a bupivacaine solution at a controlled ph which prevents its precipitation, with a suspension of giant multivescular liposomes having greater concentration of ammonium ions inside than outside, removing non-capsulated
12/14/2000WO2000074659A1 Morphine sulphate microgranules, method for preparing same and compositions containing same
12/14/2000WO2000074653A1 Oil-core compositions for the sustained release of hydrophobic drugs
12/14/2000CA2375371A1 Oil-core compositions for the sustained release of hydrophobic drugs
12/13/2000EP1058550A1 Substituted semicarbazides and the use thereof
12/07/2000WO2000072820A2 Injectable anesthetic formulation
12/07/2000CA2371033A1 Injectable anesthetic formulation
11/2000
11/30/2000WO2000045832A3 Regulation of anaesthesia
11/30/2000WO2000042989A3 Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules
11/29/2000EP1054671A1 New use for pain management
11/28/2000US6153217 Nanocochleate formulations, process of preparation and method of delivery of pharmaceutical agents
11/23/2000WO2000069515A1 Remote and local controlled delivery of pharmaceutical compounds using electromagnetic energy
1 ... 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42